Eastern Cooperative Oncology Group (ECOG)
Program Description
The Stanford ECOG Affiliates Program provides community hospitals a means to participate in national cancer clinical trials and to collaborate with members of the Stanford Cancer Center. Through this program hospital-based physicians are able to become members of the Eastern Cooperative Oncology Group (ECOG), primarily sponsored by the NCI, and one of the largest cancer clinical research organizations. Stanford ECOG personnel assist with program setup, technology transfer, and ongoing quality improvement consulting. This affiliation enables institutional involvement with colleagues on both the national and local level.
Benefits
- Institutional - ability to provide drug and treatment options not generally available to your patients, increase clinical trials participation through controlled and supported methodologies, and participate in national clinical research efforts.
- Physician - state of the art practice information, methodologies, access to new treatments, and collaborations.
- Patient - access to new drugs and treatments, controlled methodology with scrutiny, public information and standard consent procedures.
Stanford/ECOG Provides:
- Assistance with application process
- Orientation for staff
- Quality Assurance
- Collegial events and programs
- Availability of data management training
Affiliate Expectations:
- Accrual of 6 patients every 2 years
- Submit data in a timely manner
- High data quality
- Participate in audits and quality improvement efforts
- Attendance at ECOG Meetings
Getting Started
- Arrange for a briefing about the program. Stanford Cancer Center and ECOG Program members will visit your facilities, meet with your key personnel, including the Senior Investigator and Administrator, to discuss the program.
- Complete the ECOG New Affiliate Application. The Stanford ECOG Principal Investigator will write a Letter of Support.
- Upon approval, Stanford ECOG staff will visit your institution to assist with the program kickoff, which includes a briefing for key personnel and advice on clinical trial selection.
Contact Information:
| Harlan Pinto, M.D.,
Associate Professor of Medicine, ECOG Principal Investigator 650-858-3931 |
Miriam Bischoff, MS, MBA
Associate Director, Cancer Clinical Trials Office 650-498-4536 |
Trial Administration